Austin, TX, USA, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Intracranial Pressure Monitoring Devices Market Size, Trends and Insights By ...

Cerevasc today announced the first-in-human use of its eShunt system to treat medically refractory idiopathic intracranial hypertension (IIH).

Innovation created by healthtech supported by FAPESP showed the lowest estimation error among all non-invasive methods already available in the world A technology ...

Integra is recalling the CereLink Intracranial Pressure (ICP) Monitor after reports that the device may display incorrect ICP values and out-of-range pressure readings. The recall includes 388 ...

Critical care is a vital field in the world of medicine; thus, patient conditions and the decisions made by medical professionals providing care carry great weight. Moreover, the equipment used in ...

Idiopathic intracranial hypertension, also called pseudotumor cerebri, refers to elevated cerebrospinal fluid (CSF) pressure that develops most often in women of reproductive age with obesity, causing ...